Interventions to enhance medication adherence in pregnancy- a systematic review.
Adherence
Chronic disease
Maternal medicine
Medication
Perinatal outcomes
Systematic review
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
02 Mar 2023
02 Mar 2023
Historique:
received:
18
11
2021
accepted:
15
11
2022
entrez:
2
3
2023
pubmed:
3
3
2023
medline:
7
3
2023
Statut:
epublish
Résumé
Sub-optimal medication adherence in pregnant women with chronic disease and pregnancy-related indications has the potential to adversely affect maternal and perinatal outcomes. Adherence to appropriate medications is advocated during and when planning pregnancy to reduce risk of adverse perinatal outcomes relating to chronic disease and pregnancy-related indications. We aimed to systematically identify effective interventions to promote medication adherence in women who are pregnant or planning to conceive and impact on perinatal, maternal disease-related and adherence outcomes. Six bibliographic databases and two trial registries were searched from inception to 28th April 2022. We included quantitative studies evaluating medication adherence interventions in pregnant women and women planning pregnancy. Two reviewers selected studies and extracted data on study characteristics, outcomes, effectiveness, intervention description (TIDieR) and risk of bias (EPOC). Narrative synthesis was performed due to study population, intervention and outcome heterogeneity. Of 5614 citations, 13 were included. Five were RCTs, and eight non-randomised comparative studies. Participants had asthma (n = 2), HIV (n = 6), inflammatory bowel disease (IBD; n = 2), diabetes (n = 2) and risk of pre-eclampsia (n = 1). Interventions included education +/- counselling, financial incentives, text messaging, action plans, structured discussion and psychosocial support. One RCT found an effect of the tested intervention on self-reported antiretroviral adherence but not objective adherence. Clinical outcomes were not evaluated. Seven non-randomised comparative studies found an association between the tested intervention and at least one outcome of interest: four found an association between receiving the intervention and both improved clinical or perinatal outcomes and adherence in women with IBD, gestational diabetes mellitus (GDM), and asthma. One study in women with IBD reported an association between receiving the intervention and maternal outcomes but not for self-reported adherence. Two studies measured only adherence outcomes and reported an association between receiving the intervention and self-reported and/or objective adherence in women with HIV and risk of pre-eclampsia. All studies had high or unclear risk of bias. Intervention reporting was adequate for replication in two studies according to the TIDieR checklist. There is a need for high-quality RCTs reporting replicable interventions to evaluate medication adherence interventions in pregnant women and those planning pregnancy. These should assess both clinical and adherence outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Sub-optimal medication adherence in pregnant women with chronic disease and pregnancy-related indications has the potential to adversely affect maternal and perinatal outcomes. Adherence to appropriate medications is advocated during and when planning pregnancy to reduce risk of adverse perinatal outcomes relating to chronic disease and pregnancy-related indications. We aimed to systematically identify effective interventions to promote medication adherence in women who are pregnant or planning to conceive and impact on perinatal, maternal disease-related and adherence outcomes.
METHODS
METHODS
Six bibliographic databases and two trial registries were searched from inception to 28th April 2022. We included quantitative studies evaluating medication adherence interventions in pregnant women and women planning pregnancy. Two reviewers selected studies and extracted data on study characteristics, outcomes, effectiveness, intervention description (TIDieR) and risk of bias (EPOC). Narrative synthesis was performed due to study population, intervention and outcome heterogeneity.
RESULTS
RESULTS
Of 5614 citations, 13 were included. Five were RCTs, and eight non-randomised comparative studies. Participants had asthma (n = 2), HIV (n = 6), inflammatory bowel disease (IBD; n = 2), diabetes (n = 2) and risk of pre-eclampsia (n = 1). Interventions included education +/- counselling, financial incentives, text messaging, action plans, structured discussion and psychosocial support. One RCT found an effect of the tested intervention on self-reported antiretroviral adherence but not objective adherence. Clinical outcomes were not evaluated. Seven non-randomised comparative studies found an association between the tested intervention and at least one outcome of interest: four found an association between receiving the intervention and both improved clinical or perinatal outcomes and adherence in women with IBD, gestational diabetes mellitus (GDM), and asthma. One study in women with IBD reported an association between receiving the intervention and maternal outcomes but not for self-reported adherence. Two studies measured only adherence outcomes and reported an association between receiving the intervention and self-reported and/or objective adherence in women with HIV and risk of pre-eclampsia. All studies had high or unclear risk of bias. Intervention reporting was adequate for replication in two studies according to the TIDieR checklist.
CONCLUSIONS
CONCLUSIONS
There is a need for high-quality RCTs reporting replicable interventions to evaluate medication adherence interventions in pregnant women and those planning pregnancy. These should assess both clinical and adherence outcomes.
Identifiants
pubmed: 36864375
doi: 10.1186/s12884-022-05218-5
pii: 10.1186/s12884-022-05218-5
pmc: PMC9979410
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
135Informations de copyright
© 2023. The Author(s).
Références
Prev Chronic Dis. 2018 Feb 08;15:E21
pubmed: 29420168
Pregnancy Hypertens. 2016 Oct;6(4):350-355
pubmed: 27939481
AIDS Behav. 2019 Nov;23(11):3140-3151
pubmed: 31410618
Inflamm Bowel Dis. 2021 Nov 15;27(12):1909-1918
pubmed: 33704467
Patient Educ Couns. 1999 Jun;37(2):113-24
pubmed: 14528539
BJOG. 2011 Oct;118(11):1314-23
pubmed: 21749633
Transl Behav Med. 2015 Dec;5(4):470-82
pubmed: 26622919
Frontline Gastroenterol. 2020 May 19;12(3):214-224
pubmed: 33912333
Inflamm Bowel Dis. 2014 Jun;20(6):1091-8
pubmed: 24810137
JAMA Neurol. 2017 Aug 1;74(8):983-991
pubmed: 28672292
Eur J Hosp Pharm. 2019 Jul;26(4):187-192
pubmed: 31338165
Hypertension. 2018 Jul;72(1):202-207
pubmed: 29802215
Am J Gastroenterol. 2007 Sep;102(9):1947-54
pubmed: 17573787
Expert Opin Drug Saf. 2021 Sep;20(9):1117-1124
pubmed: 34080506
J Crohns Colitis. 2016 Aug;10(8):892-7
pubmed: 26896087
RMD Open. 2019 Apr 14;5(1):e000878
pubmed: 31168407
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD003094
pubmed: 21975735
Int J Behav Med. 2023 Feb;30(1):62-76
pubmed: 35260947
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Midwifery Womens Health. 2019 Jul;64(4):451-461
pubmed: 31222899
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1379-1383
pubmed: 32755838
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
J Basic Clin Physiol Pharmacol. 2020 Jan 13;30(6):
pubmed: 31927518
Eur Respir J. 2005 Sep;26(3):435-41
pubmed: 16135724
Clin Gastroenterol Hepatol. 2016 Sep;14(9):1285-1292.e1
pubmed: 27001269
BMC Pregnancy Childbirth. 2018 Jun 14;18(1):230
pubmed: 29898689
BMJ Open. 2014 Feb 17;4(2):e004365
pubmed: 24534260
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Trials. 2018 Mar 27;19(1):204
pubmed: 29587864
Gastroenterol Hepatol (N Y). 2015 Feb;11(2):96-102
pubmed: 27099578
Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):391-403
pubmed: 21333604
Arthritis Care Res (Hoboken). 2019 Aug;71(8):1019-1027
pubmed: 30133181
J Int Assoc Provid AIDS Care. 2014 May-Jun;13(3):269-76
pubmed: 23778240
BMC Public Health. 2018 Jun 27;18(1):805
pubmed: 29945601
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Eur J Epidemiol. 2012 Mar;27(3):205-14
pubmed: 22286718
Health Psychol. 2006 Jul;25(4):462-73
pubmed: 16846321
J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S124-9
pubmed: 27355499
BMJ Open. 2020 Feb 5;10(2):e034529
pubmed: 32029496
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011
pubmed: 25412402
Obstet Gynecol. 2017 Dec;130(6):1319-1326
pubmed: 29112666
BMJ Open. 2018 Jan 21;8(1):e016982
pubmed: 29358417
BJOG. 2017 Apr;124(5):804-813
pubmed: 27510598
Glob Health Sci Pract. 2020 Mar 31;8(1):55-67
pubmed: 32139420
Respiration. 2016;92(1):9-15
pubmed: 27348313
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547